An Integrative Review of Systematic Reviews Related to the Management of Breathlessness in Respiratory Illnesses

Overview

Journal BMC Pulm Med

Publisher Biomed Central

Specialty Pulmonary Medicine

Date 2010 Dec 15

PMID 21143887

Citations 13

Authors

Chris D Bailey

Richard Wagland

Rasha Dabbour

Ann Caress

Jaclyn Smith

Alex Molassiotis

Affiliations

Soon will be listed here.

Abstract

Background: Breathlessness is a debilitating and distressing symptom in a wide variety of diseases and still a difficult symptom to manage. An integrative review of systematic reviews of non-pharmacological and pharmacological interventions for breathlessness in non-malignant disease was undertaken to identify the current state of clinical understanding of the management of breathlessness and highlight promising interventions that merit further investigation.

Methods: Systematic reviews were identified via electronic databases between July 2007 and September 2009. Reviews were included within the study if they reported research on adult participants using either a measure of breathlessness or some other measure of respiratory symptoms.

Results: In total 219 systematic reviews were identified and 153 included within the final review, of these 59 addressed non-pharmacological interventions and 94 addressed pharmacological interventions. The reviews covered in excess of 2000 trials. The majority of systematic reviews were conducted on interventions for asthma and COPD, and mainly focussed upon a small number of pharmacological interventions such as corticosteroids and bronchodilators, including beta-agonists. In contrast, other conditions involving breathlessness have received little or no attention and studies continue to focus upon pharmacological approaches. Moreover, although there are a number of non-pharmacological studies that have shown some promise, particularly for COPD, their conclusions are limited by a lack of good quality evidence from RCTs, small sample sizes and limited replication.

Conclusions: More research should focus in the future on the management of breathlessness in respiratory diseases other than asthma and COPD. In addition, pharmacological treatments do not completely manage breathlessness and have an added burden of side effects. It is therefore important to focus more research on promising non-pharmacological interventions.

Citing Articles

Effect of exercise on postoperative recovery of patients with non-small cell lung cancer: a systematic review and meta-analysis.

Jiao M, Liang H, Zhang M Discov Oncol. 2024; 15(1):230.

PMID: 38884823 PMC: 11183035. DOI: 10.1007/s12672-024-01079-w.

Effects and Usefulness of Inspiratory Muscle Training Load in Patients with Advanced Lung Cancer with Dyspnea.

Sakai Y, Yamaga T, Yamamoto S, Matsumori K, Ichiyama T, Hanaoka M J Clin Med. 2023; 12(10).

PMID: 37240502 PMC: 10219417. DOI: 10.3390/jcm12103396.

Palliative Care Early in the Care Continuum among Patients with Serious Respiratory Illness: An Official ATS/AAHPM/HPNA/SWHPN Policy Statement.

Sullivan D, Iyer A, Enguidanos S, Cox C, Farquhar M, Janssen D Am J Respir Crit Care Med. 2022; 206(6):e44-e69.

PMID: 36112774 PMC: 9799127. DOI: 10.1164/rccm.202207-1262ST.

Verifying intervention fidelity procedures for a palliative home care intervention with pilot study results.

Piamjariyakul U, Smothers A, Young S, Morrissey E, Petitte T, Wen S Res Nurs Health. 2021; 44(5):854-863.

PMID: 34196013 PMC: 8440457. DOI: 10.1002/nur.22166.

A Randomized Controlled Trial of a Non-pharmacological Intervention for Cancer-Related Dyspnea.

Yates P, Hardy J, Clavarino A, Fong K, Mitchell G, Skerman H Front Oncol. 2020; 10:591610.

PMID: 33335858 PMC: 7737519. DOI: 10.3389/fonc.2020.591610.

References

Ni Chroinin M, Greenstone I, Danish A, Magdolinos H, Masse V, Zhang X . Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma. Cochrane Database Syst Rev. 2005; (4):CD005535. DOI: 10.1002/14651858.CD005535. View

Walters E, Gibson P, Lasserson T, Walters J . Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid. Cochrane Database Syst Rev. 2007; (1):CD001385. PMC: 10849111. DOI: 10.1002/14651858.CD001385.pub2. View

Barr R, Bourbeau J, Camargo C, Ram F . Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis. Thorax. 2006; 61(10):854-62. PMC: 2104759. DOI: 10.1136/thx.2006.063271. View

Yang I, Fong K, Sim E, Black P, Lasserson T . Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2007; (2):CD002991. DOI: 10.1002/14651858.CD002991.pub2. View

Gibson P, Henry R, Coughlan J . Gastro-oesophageal reflux treatment for asthma in adults and children. Cochrane Database Syst Rev. 2003; (2):CD001496. DOI: 10.1002/14651858.CD001496. View

Appleton S, Jones T, Poole P, Pilotto L, Adams R, Lasserson T . Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006; (3):CD006101. PMC: 7200053. DOI: 10.1002/14651858.CD006101. View

Liesker J, Wijkstra P, Ten Hacken N, Koeter G, Postma D, Kerstjens H . A systematic review of the effects of bronchodilators on exercise capacity in patients with COPD. Chest. 2002; 121(2):597-608. DOI: 10.1378/chest.121.2.597. View

Cranston J, Crockett A, Moss J, Alpers J . Domiciliary oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2005; (4):CD001744. PMC: 6464709. DOI: 10.1002/14651858.CD001744.pub2. View

Manser R, Reid D, Abramson M . Corticosteroids for acute severe asthma in hospitalised patients. Cochrane Database Syst Rev. 2001; (1):CD001740. DOI: 10.1002/14651858.CD001740. View

10.

Geddes E, Reid W, Crowe J, OBrien K, Brooks D . Inspiratory muscle training in adults with chronic obstructive pulmonary disease: a systematic review. Respir Med. 2005; 99(11):1440-58. DOI: 10.1016/j.rmed.2005.03.006. View

11.

McCarney R, Linde K, Lasserson T . Homeopathy for chronic asthma. Cochrane Database Syst Rev. 2004; (1):CD000353. PMC: 7032670. DOI: 10.1002/14651858.CD000353.pub2. View

12.

Bradley J, ONeill B . Short-term ambulatory oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2005; (4):CD004356. PMC: 9039969. DOI: 10.1002/14651858.CD004356.pub3. View

13.

Smith J, Mugford M, Holland R, Candy B, Noble M, Harrison B . A systematic review to examine the impact of psycho-educational interventions on health outcomes and costs in adults and children with difficult asthma. Health Technol Assess. 2005; 9(23):iii-iv, 1-167. DOI: 10.3310/hta9230. View

14.

Spooner C, Spooner G, Rowe B . Mast-cell stabilising agents to prevent exercise-induced bronchoconstriction. Cochrane Database Syst Rev. 2003; (4):CD002307. PMC: 8985571. DOI: 10.1002/14651858.CD002307. View

15.

Seamark D, Blake S, Seamark C, Halpin D . Living with severe chronic obstructive pulmonary disease (COPD): perceptions of patients and their carers. An interpretative phenomenological analysis. Palliat Med. 2004; 18(7):619-25. DOI: 10.1191/0269216304pm928oa. View

16.

Turnock A, Walters E, Walters J, Wood-Baker R . Action plans for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2005; (4):CD005074. DOI: 10.1002/14651858.CD005074.pub2. View

17.

Evans D, Bara A, Greenstone M . Prolonged antibiotics for purulent bronchiectasis in children and adults. Cochrane Database Syst Rev. 2007; (2):CD001392. DOI: 10.1002/14651858.CD001392.pub2. View

18.

Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik M, Yohannes A . Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008; 134(4 Suppl):43S-56S. PMC: 2849676. DOI: 10.1378/chest.08-0342. View

19.

Ni C, Greenstone I, Ducharme F . Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults. Cochrane Database Syst Rev. 2005; (2):CD005307. DOI: 10.1002/14651858.CD005307. View

20.

Appleton S, Jones T, Poole P, Pilotto L, Adams R, Lasserson T . Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006; (2):CD001387. PMC: 6513456. DOI: 10.1002/14651858.CD001387.pub2. View